Pirfenidone and Prograf drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pirfenidone (pirfenidone) and Prograf (tacrolimus). Common drug interactions include dyspnoea among females and herpes zoster among males.

The phase IV clinical study analyzes what interactions people have when they take Pirfenidone and Prograf. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Pirfenidone?

Pirfenidone has active ingredients of pirfenidone. eHealthMe is studying from 2,648 Pirfenidone users. Check the latest studies of Pirfenidone.

What is Prograf?

Prograf has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 42,230 Prograf users. Check the latest studies of Prograf.



On Jul, 29, 2026

13 people who take Pirfenidone and Prograf together, and have interactions are studied.

Pirfenidone and Prograf drug interactions.

What are the common drug interactions of Pirfenidone and Prograf, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cough
  3. Chest discomfort
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. General physical health deterioration (weak health status)
  7. Heart rate increased
  8. Hypoxia (low oxygen in tissues)
  9. Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
  10. Wheezing (a high-pitched whistling sound made while you breath)

male:

  1. Herpes zoster
  2. Abdominal pain
  3. Blood sodium decreased
  4. C-reactive protein increased
  5. Diarrhoea
  6. Drug level increased
  7. Dyspnoea (difficult or laboured respiration)
  8. Haematocrit decreased
  9. Haemoglobin decreased
  10. Haemoglobin increased

What are the common drug interactions of Pirfenidone and Prograf, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dyspnoea (difficult or laboured respiration)

30-39:

n/a

40-49:

n/a

50-59:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Hypoxia (low oxygen in tissues)
  5. Pneumonia respiratory syncytial viral (respiratory syncytial virus (rsv) is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children)
  6. Transplant rejection (a transplant material is not worked)

60+:

  1. Herpes zoster
  2. Dyspnoea (difficult or laboured respiration)
  3. Blood potassium increased
  4. Blood sodium decreased
  5. C-reactive protein increased
  6. Diarrhoea
  7. Drug level increased
  8. General physical health deterioration (weak health status)
  9. Haematocrit decreased
  10. Haemoglobin decreased

What are the existing conditions these people have? *

  1. Obliterative Bronchiolitis (bronchiolar inflammation): 7 people, 53.85%
  2. Interstitial Lung Disease: 2 people, 15.38%
  3. Tachyarrhythmia (disturbance of the heart rhythm in which the heart rate is abnormally increased): 1 person, 7.69%
  4. Nausea (feeling of having an urge to vomit): 1 person, 7.69%
  5. Ischaemic Stroke (stroke; caused by an interruption in the flow of blood to the brain): 1 person, 7.69%
  6. Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 7.69%
  7. Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 1 person, 7.69%
  8. Hypersensitivity: 1 person, 7.69%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
  10. Embolism Venous (embolus may pass into the arterial system): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Pirfenidone and Prograf?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pirfenidone and Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pirfenidone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prograf:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pirfenidone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prograf and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pirfenidone and tacrolimus (the active ingredients of Pirfenidone and Prograf, respectively), and Pirfenidone and Prograf (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: